投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2018年中国人文章占该期刊总数量暂无数据 (2017年为暂无数据)
自引率
暂无数据
年文章数
0
投稿链接
未知
作者需知
暂无数据
NCBI查询
偏重的研究方向
暂无数据
期刊简介
稿件收录要求
稿件收录要求
Clinical Lymphoma & Myeloma is the world’s premier peer-reviewed, tumor-specific, clinical oncology journal devoted to publishing clinically relevant articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, and related disorders. Indexed in Index Medicus/Medline/Pubmed, ISI (Current Contents/Clinical Medicine, Science Citation Index Expanded (Web of Science), Journal Citation Reports, Derwent Drug File, Prous), EMBASE, CINAHL, and Chemical Abstracts. Each issue of Clinical Lymphoma & Myeloma features peer-reviewed original contributions, invited comprehensive reviews, and current trials reports, as well as "Meeting Highlights" reports taken from major oncology meetings each year. Also included are brief editorials of current news and the latest topics concerning lymphoma and myeloma for the clinician.
